R. Yang et al., ALPHA-1-PROTEINASE INHIBITOR PROLONGS SMALL-INTESTINAL GRAFT PRESERVATION AND SURVIVAL, Journal of pediatric surgery, 31(8), 1996, pp. 1052-1055
Organ preservation solutions currently used for cold storage of human
donor organs are less effective in preserving small intestinal grafts
than other organ grafts. The maximal safe period of cold preservation
for human small intestinal graft is only about 6 hours. The pathology
of preserved and reperfused small intestinal grafts is characterized b
y mucosal autolysis and sloughing. The authors specu lated that the pr
eservation/reperfusion injury results from a proteinase/proteinase inh
ibitor imbalance in the graft that favors tissue degradation. This stu
dy evaluates whether the addition of an alpha-l-proteinase inhibitor (
alpha-1-PI) to the preservation solution can improve graft survival af
ter small bowel transplantation. Forty small intestinal grafts (20 cm
long) were harvested from Lewis rats. The grafts were divided randomly
into three groups and were preserved in one of the following solution
s: normal saline (NS) (n = 10), alpha-1-PI (25 mg/mL; n = 20), or prot
einase-free bovine serum albumin (BSA) (25 mg/mL; n = 10). After la-ho
ur cold storage in the respective solutions, the grafts were transplan
ted orthotopically into syngeneic recipients. Full thickness graft bio
psies were performed before and 1 hour after revascularization. The ef
fectiveness of preservation was judged by graft histopathology and rec
ipient survival. Histological studies showed that there was less mucos
al autolysis and sloughing of the grafts in the alpha-1-PI group than
in the other two groups. All recipients in the NS and BSA groups died
of graft failure within 7 days (NS: median, 4 days; range, 2 to 5 days
; BSA: median, 6 days; range, 4 to 7). However, 60% (12 of 20) of the
recipients in the alpha-1-PI group survived more than 90 days (median,
>90 days; range, 4 to >90 days; P <.005 v NS or BSA groups, log-rank
method). These data suggest that the inclusion of alpha-1-PI in the pr
eservation solution may enhance graft integrity and improve the surgic
al outcome after small bowel transplantation. Copyright (C) 1996 by W.
B. Saunders Company